🔎 Trials Near Me

Nyumbani › Scleroderma › New York › New York City

Majaribio ya kliniki ya Scleroderma katika New York City, NY

Masomo 11 ya Scleroderma yanatafuta washiriki katika vituo vya New York City na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.

Maandishi rasmi ya utafiti (Kiingereza)

Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

InaajiriHatua 3
  • Hospital for Special Surgery, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • Columbia University Medical Center-New York Presbyterian Hospital, New York
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07497087

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

InaajiriHatua 1
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • NYP/Weill Cornell Medical Center, New York
Umri 18 na zaidi · Jinsia zote · Imesasishwa 23 Sep 2026 · NCT03816345

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

InaajiriHatua 1
  • Icahn School of Medicine at Mount Sinai, New York
Umri 18 hadi 74 · Jinsia zote · Imesasishwa 10 Sep 2026 · NCT07085104

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

InaajiriHatua 2/3
  • GSK Investigational Site, New York
  • GSK Investigational Site, New York
Umri 18 na zaidi · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT05878717

Platform Clinical Study for Conquering Scleroderma

InaajiriHatua 2
  • Hospital for Special Surgery, New York
  • Columbia University Medical Center, New York
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Ago 2026 · NCT06195072

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

InaajiriHatua 2/3
  • Columbia University Irving Medical Center, New York
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 17 Ago 2026 · NCT06328777

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

InaajiriHatua 1/2
  • Nkarta Investigational Site, New York
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 7 Ago 2026 · NCT06733935

A Study of AZD0120 in Autoimmune Diseases

InaajiriHatua 1
  • Research Site, New York
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 28 Jul 2026 · NCT07295847

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

InaajiriHatua 1
  • Montefiore Medical Center, New York
Umri 12 hadi 70 · Jinsia zote · Imesasishwa 22 Mei 2026 · NCT06308978

Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis

InaajiriHatua 2
  • Hospital for Special Surgery, New York
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 27 Mac 2026 · NCT03844061

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

InaajiriHatua 2
  • aTyr Investigative Site, New York
Umri 18 na zaidi · Jinsia zote · Imesasishwa 7 Mei 2025 · NCT05892614

Majaribio ya Scleroderma katika miji mingine

Masomo mengine katika New York City

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.